长江经济带林地和其他生物质碳储量及碳汇量研究

以全国林业应对气候变化碳汇计量监测体系建设结果数据为基础，应用森林碳库专项调查建立的碳计量模型和参数，结合历次森林资源清查成果等数据，估算了2020年长江经济带林地和其他生物质碳储量和碳汇量。研究表明：（1）2020年长江经济带林地碳储量24543.58 Tg C （其中森林植被碳储量为4372.85Tg C），散生木和四旁树等其他生物质碳储量329.59 Tg C。2020年长江经济带林地碳汇量81.81 Tg C/a （300.26Tg CO₂/a）、散生木和四旁树等其他生物质碳汇量6.60 Tg C/a （24.21 Tg CO₂/a）。无论是林地和其他生物质碳储量、碳汇量、还是森林植被碳储量，乔木林地所占比例最大（69%-85%）；长江经济带11个省市中，云南省最大，上海市最小；林地碳储量中土壤有机质碳库贡献最大（81.46%），林地碳汇量中生物量碳库贡献最大（90.99%）；林地碳汇量中"一直为林地的土地"产生碳汇量贡献最大（71.74%），其中一直为乔木林的土地产生的碳汇量占69.89%；（2）阐述了长江防护林工程、天然林资源保护工程、珠江防护林工程和沿海防护林工程4大重点生态工程对长江经济带碳储量和碳汇量的贡献，长江防护林工程贡献率最大（81%-83%），其次是天然林资源保护工程（32%-38%），珠江防护林工程和沿海防护林工程影响较小。分析了人工造林、中幼林抚育、次生林和低效林改造、退化林修复等生态保护修复措施对长江经济带碳储量和碳汇量的贡献，并提出了碳中和愿景下森林固碳增汇的有效途径。     

Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors

Rhabdomyosarcoma is the most common soft tissue sarcoma of childhood and appears to arise from developing striated muscle-forming cells. Since insulin-like growth factor II (IGF-II) is involved in normal muscle growth and maturation and elevated IGF-II mRNA levels have previously been reported in rhabdomyosarcomas, we have been studying the possible role of IGF-II in the unregulated growth and invasive potential of these embryonal tumors. In this study, we demonstrate that 13 of 14 rhabdomyosarcoma tumors express high levels of IGF-II mRNA relative to normal adult muscle and also express mRNA for the type I IGF receptors on their cell surface, the receptor thought to mediate the effects of IGF-II on muscle cells. We have established several rhabdomyosarcoma cell lines in mitogen-free media and demonstrate that these cells express type I IGF receptors on their cell surface and secrete IGF-II into the media. Exogenous IGF-II is able to stimulate cellular motility in these cell lines as assayed in a modified Boyden chamber. Finally, alpha IR-3, a type I receptor antagonist, inhibits the growth of these cell lines in serum-free media but does not inhibit IGF-II-induced motility of these cells. These data suggest that endogenously produced IGF-II functions as an autocrine growth and motility factor in many rhabdomyosarcoma tumors. The mitogenic actions of IGF-II are mediated through a domain of the type I IGF receptor that is blocked by alpha IR-3. IGF-II-induced motility may be mediated through an alternative signaling pathway.